Clinical outcomes of partial sialoadenectomy for the treatment of benign tumors in the submandibular gland

  • Yuanyuan YANG ,
  • Shanshan ZHANG ,
  • Guangyan YU ,
  • Huijun YANG ,
  • Hongyu YANG
Expand
  • 1. Department of General Dentistry Ⅱ, Peking University School and Hospital of Stomatology & National Center for Stomatology & National Clinical Research Center for Oral Diseases & National Engineering Research Center of Oral Biomaterials and Digital Medical Devices & Beijing Key Laboratory of Digital Stomatology, Beijing 100081, China
    2. Department of Oral and Maxillofacial Surgery, Stomatological Center, Peking University Shenzhen Hospital & Guangdong Province High-level Clinical Key Specialty & Guangdong Province Engineering Research Center of Oral Disease Diagnosis and Treatment, Shenzhen 518036, Guangdong, China
    3. Department of Oral and Maxillofacial Surgery, Peking University School and Hospital of Stomatology, Beijing 100081, China
YANG Huijun, e-mail, yanghj8801019@163.com
YANG Hongyu, e-mail, hyyang192@hotmail.com

Received date: 2022-06-27

  Online published: 2025-04-12

Supported by

the Sanming Project of Medicine in Shenzhen(SZSM202111012);Shenzhen Fund for Guangdong Provincial High-level Clinical Key Specialties(SZGSP008);Shenzhen Health and Family Planning System Research Project(SZXJ2018078)

Copyright

, 2025, All rights reserved. Unauthorized reproduction is prohibited.

Abstract

Objective: To evaluate the clinical outcomes and explore the application of partial sialoadenectomy for the treatment of benign tumors in the submandibular gland (SMG). Methods: Patients with pleomorphic adenoma of the SMG who underwent surgical treatment in the Department of Oral and Maxillofacial Surgery, Peking University Shenzhen Hospital, from October 2017 to February 2021, were enrolled and assessed in the follow-up. Fifteen patients underwent partial sialoadenectomy (PS group), and 18 patients underwent total sialoadenectomy (TS group). Postoperative salivary secretion, degree of dry mouth, appearance changes of the face and neck, nerve damage, and tumor recurrence were compared between the groups. The volume of the glands on the operated and contralateral sides of the patients in the PS group, the saliva flow rate, and their correlations, were also analyzed. Results: There was no recurrence during the follow-up period. The whole saliva flow rate at rest in the PS group was higher than that in the TS group [(2.15±1.10) g/5 min vs. (1.35±0.97) g/5 min, t=2.208, P=0.035)], while the stimulated saliva flow rate was not significantly different. The objective feeling of dry mouth, evaluated by visual analogue scale (VAS) score, was more obvious in the TS group than in the PS group (Z=-2.244, P=0.025). In the PS group, the resting saliva flow rate of the SMG on the operated side was lower than that on the contralateral side of the same patient [(0.92±0.40) g/5 min vs. (1.18±0.40) g/5 min, t=-2.821, P=0.014], however, in the cases whose remaining SMG was more than 80% of the contralateral side, the saliva flow rate of both sides was not significantly different (t=-0.027, P=0.980). There was no significant difference in the saliva flow rate per unit volume of the gland on either side (t=-0.015, P=0.989), and the saliva flow rate of the operated SMG was positively correlated with the volume of the remaining gland (r=0.750, P=0.012). The VAS scores for neck deformity were not significantly different between the two groups (t=-0.997, P=0.319). No symptoms of nerve injury occurred in either group. Conclusion: Partial sialoadenectomy in the SMG can safely remove benign tumors while preserving glandular secretory function, with fewer complications and improved quality of life.

Cite this article

Yuanyuan YANG , Shanshan ZHANG , Guangyan YU , Huijun YANG , Hongyu YANG . Clinical outcomes of partial sialoadenectomy for the treatment of benign tumors in the submandibular gland[J]. Journal of Peking University(Health Sciences), 2025 , 57(2) : 334 -339 . DOI: 10.19723/j.issn.1671-167X.2025.02.018

References

1 Roblegg E , Coughran A , Sirjani D . Saliva: An all-rounder of our body[J]. Eur J Pharm Biopharm, 2019, 142, 133- 141.
2 Carpenter GH . The secretion, components, and properties of saliva[J]. Annu Rev Food Sci Technol, 2013, 4, 267- 276.
3 de Brito Neves CP , Lira RB , Chulam TC , et al. Retroauricular endoscope-assisted versus conventional submandibular gland excision for benign and malignant tumors[J]. Surg Endosc, 2020, 34 (1): 39- 46.
4 Cammaroto G , Vicini C , Montevecchi F , et al. Submandibular gland excision: From external surgery to robotic intraoral and extraoral approaches[J]. Oral Dis, 2020, 26 (5): 853- 857.
5 Dhiwakar M , Ronen O , Malone J , et al. Feasibility of submandi-bular gland preservation in neck dissection: A prospective anatomic-pathologic study[J]. Head Neck, 2011, 33 (5): 603- 609.
6 Proctor GB , Shaalan AM . Disease-induced changes in salivary gland function and the composition of saliva[J]. J Dent Res, 2021, 100 (11): 1201- 1209.
7 Yu GY , Ma DQ , Liu XB , et al. Local excision of the parotid gland in the treatment of Warthin' s tumour[J]. Br J Oral Maxillofac Surg, 1998, 36 (3): 186- 189.
8 Roh JL , Park CI . Gland-preserving surgery for pleomorphic adenoma in the submandibular gland[J]. Br J Surg, 2008, 95 (10): 1252- 1256.
9 Xu H , Mao C , Liu JM , et al. Microanatomic study of the vascular and duct system of the submandibular gland[J]. J Oral Maxillofac Surg, 2011, 69 (4): 1103- 1107.
10 Min R , Zun Z , Siyi L , et al. Gland-preserving surgery can effectively preserve gland function without increased recurrence in treatment of benign submandibular gland tumour[J]. Br J Oral Maxillofac Surg, 2013, 51 (7): 615- 619.
11 Yang TL , Ko JY , Lou PJ , et al. Gland-preserving robotic surgery for benign submandibular gland tumours: A comparison between robotic and open techniques[J]. Br J Oral Maxillofac Surg, 2014, 52 (5): 420- 424.
12 Ge N , Peng X , Zhang L , et al. Partial sialoadenectomy for the treatment of benign tumours in the submandibular gland[J]. Int J Oral Maxillofac Surg, 2016, 45 (6): 750- 755.
13 李巍, 孙志鹏, 刘筱菁, 等. 腮腺和颌下腺体积的测量[J]. 北京大学学报(医学版), 2014, 46 (2): 288- 293.
14 Huang L , Wang Z , Shan Z , et al. Nasal asymmetry changes during growth and development in 6- to 12-year-old children with repaired unilateral cleft lip and palate: A 3D computed tomography analysis[J]. J Anat, 2022, 240 (1): 155- 165.
15 俞光岩. 要重视下颌下腺功能器官的保护[J]. 中华口腔医学杂志, 2017, 52 (4): 204- 205.
16 Ethunandan M , Davies B , Pratt CA , et al. Primary epithelial submandibular salivary gland tumours: Review of management in a district general hospital setting[J]. Oral Oncol, 2009, 45 (2): 173- 176.
17 Li LJ , Li Y , Wen YM , et al. Clinical analysis of salivary gland tumor cases in West China in past 50 years[J]. Oral Oncol, 2008, 44 (2): 187- 192.
18 Tian Z , Li L , Wang L , et al. Salivary gland neoplasms in oral and maxillofacial regions: A 23-year retrospective study of 6 982 cases in an eastern Chinese population[J]. Int J Oral Maxillofac Surg, 2010, 39 (3): 235- 242.
19 Gao M , Hao Y , Huang MX , et al. Salivary gland tumours in a northern Chinese population: A 50-year retrospective study of 7 190 cases[J]. Int J Oral Maxillofac Surg, 2017, 46 (3): 343- 349.
20 Hu Y , Zheng C , Cao R , et al. Resection of benign tumours of the submandibular gland with harmonic scalpel-assisted minimally extracapsular dissection[J]. J Int Med Res, 2020, 48 (1): 300060519892783.
21 Li L , Gao XL , Song YZ , et al. Anatomy of arteries and veins of submandibular glands[J]. Chin Med J (Engl), 2007, 120 (13): 1179- 1182.
22 Garcia-Serrano G , Mo?ux A , Maranillo E , et al. Vascular clinical anatomy of the submandibular gland[J]. J Craniomaxillofac Surg, 2020, 48 (6): 582- 589.
23 王张嵩, 谢舒乐, 张汉卿, 等. 2 456例唾液腺肿瘤临床病理分析[J]. 口腔疾病防治, 2020, 28 (5): 298- 302.
24 Andreasen S , Therkildsen MH , Bj?rndal K , et al. Pleomorphic adenoma of the parotid gland 1985-2010: A Danish nationwide study of incidence, recurrence rate, and malignant transformation[J]. Head Neck, 2016, 38 (Suppl 1): E1364- E1369.
25 Dai L , Lou W , Fang Q , et al. Recurrent pleomorphic adenoma of the parotid gland: Experience of 128 patients with first recurrence[J]. J Oncol, 2020, 2020, 6645340.
26 Valstar MH , de Ridder M , van den Broek EC , et al. Salivary gland pleomorphic adenoma in the Netherlands: A nationwide observational study of primary tumor incidence, malignant transformation, recurrence, and risk factors for recurrence[J]. Oral Oncol, 2017, 66, 93- 99.
27 Roldan-Valadez E , Garcia-Ulloa AC , Gonzalez-Gutierrez O , et al. 3D volumetry comparison using 3T magnetic resonance imaging between normal and adenoma-containing pituitary glands[J]. Neurol India, 2011, 59 (5): 696- 699.
28 王怡平, 蔡志刚, 彭歆, 等. 下颌下腺质量和体积的实体体外检测[J]. 北京大学学报(医学版), 2021, 53 (1): 126- 132.
29 Hong X , Zhang YY , Li W , et al. Treatment of immunoglobulin G4-related sialadenitis: Outcomes of glucocorticoid therapy combined with steroid-sparing agents[J]. Arthritis Res Ther, 2018, 20 (1): 12.
Outlines

/